Literature DB >> 22779913

Increased salivary chromogranin A in women with severe negative mood states in the premenstrual phase.

Tamaki Matsumoto1, Hiroyuki Asakura, Tatsuya Hayashi.   

Abstract

The present study investigated whether salivary chromogranin A (CgA), a psychological stress marker associated with sympathetic nervous system activity, changes during the menstrual cycle in women with different degrees of premenstrual psychoemotional symptoms. Forty-five women (28.6 ± 1.3 years) with regular menstrual cycles participated in this study. Salivary CgA and cortisol were measured during the follicular and late-luteal phases. The authors used the Profile of Mood State (POMS) to assess current mood states of subjects in each menstrual phase and divided the subjects into three groups depending on increase of total mood disturbance (TMD), a global measure of affective states of POMS from the follicular to the late-luteal phase: Low (4.1 ± 0.7%), Middle (18.7 ± 1.2%) and High (51.7 ± 7.4%). Results showed no intramenstrual cycle differences in salivary CgA in the Low and Middle groups. Women in the High group, in contrast, had a significantly higher level of salivary CgA in the late-luteal phase compared to that of the follicular phase. Additionally, salivary CgA level significantly and positively correlated with TMD and four emotional subscales: tension-anxiety, depression-dejection, anger-hostility and confusion in the late-luteal phase. No intergroup or menstrual-cycle difference occurred in the salivary cortisol. This study indicates a significant late-luteal increase in salivary CgA, reflecting an increase of sympathetic nerve activity in women who experience a substantial increase (>30%) in a cluster of negative psychoemotional symptoms premenstrually. Furthermore, salivary CgA, as opposed to salivary cortisol, could serve as a reliable noninvasive biomarker to more sensitively evaluate neuropsychophysiological fluctuations during the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22779913     DOI: 10.3109/0167482X.2012.697498

Source DB:  PubMed          Journal:  J Psychosom Obstet Gynaecol        ISSN: 0167-482X            Impact factor:   2.949


  7 in total

1.  Effects of olfactory stimulation from the fragrance of the Japanese citrus fruit yuzu (Citrus junos Sieb. ex Tanaka) on mood states and salivary chromogranin A as an endocrinologic stress marker.

Authors:  Tamaki Matsumoto; Hiroyuki Asakura; Tatsuya Hayashi
Journal:  J Altern Complement Med       Date:  2014-04-17       Impact factor: 2.579

2.  Associations between chronic work stress and plasma chromogranin A/catestatin among healthy workers.

Authors:  Xin Liu; Weimin Dang; Hui Liu; Yao Song; Ying Li; Weixian Xu
Journal:  J Occup Health       Date:  2022-01       Impact factor: 2.570

3.  Aromatic effects of a Japanese citrus fruit-yuzu (Citrus junos Sieb. ex Tanaka)-on psychoemotional states and autonomic nervous system activity during the menstrual cycle: a single-blind randomized controlled crossover study.

Authors:  Tamaki Matsumoto; Tetsuya Kimura; Tatsuya Hayashi
Journal:  Biopsychosoc Med       Date:  2016-04-21

4.  Biological function and clinical relevance of chromogranin A and derived peptides.

Authors:  Maria Angela D'amico; Barbara Ghinassi; Pascal Izzicupo; Lamberto Manzoli; A Di Baldassarre
Journal:  Endocr Connect       Date:  2014-04-29       Impact factor: 3.335

5.  A potential relation between premenstrual symptoms and subjective perception of health and stress among college students: a cross-sectional study.

Authors:  Tamaki Matsumoto; Miho Egawa; Tetsuya Kimura; Tatsuya Hayashi
Journal:  Biopsychosoc Med       Date:  2019-10-31

6.  Gene Signatures Associated with Temporal Rhythm as Diagnostic Markers of Major Depressive Disorder and Their Role in Immune Infiltration.

Authors:  Jing Wang; Pan Ai; Yi Sun; Hui Shi; Anshi Wu; Changwei Wei
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

7.  Does lavender aromatherapy alleviate premenstrual emotional symptoms?: a randomized crossover trial.

Authors:  Tamaki Matsumoto; Hiroyuki Asakura; Tatsuya Hayashi
Journal:  Biopsychosoc Med       Date:  2013-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.